Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesMolecular Characterization of Reactive Oxygen Species in Myocardial Ischemia-Reperfusion InjuryStenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trialsThe role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioningRemote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute WorkshopRole of the MPTP in conditioning the heart - translatability and mechanismIschaemic postconditioning: cardiac protection after the eventCardioprotection during cardiac surgeryIschaemic conditioning: pitfalls on the path to clinical translationPostconditioning signalling in the heart: mechanisms and translatabilityThe mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotectionIntermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptorsA New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat ModelUrocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2Effects of sildenafil and/or muscle derived stem cells on myocardial infarction.Berbamine postconditioning protects the heart from ischemia/reperfusion injury through modulation of autophagyRemote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysisImpaired intestinal mucosal barrier upon ischemia-reperfusion: "patching holes in the shield with a simple surgical method".Endothelial NOS activity and myocardial oxygen metabolism define the salvageable ischemic time window for ischemic postconditioning.Novel adjunctive treatments of myocardial infarction.Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury.Protective effect of oxysophoridine on cerebral ischemia/reperfusion injury in mice.Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model.Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.HIF-1α signaling activation by post-ischemia treatment with astragaloside IV attenuates myocardial ischemia-reperfusion injury.Motor deficits are triggered by reperfusion-reoxygenation injury as diagnosed by MRI and by a mechanism involving oxidants.Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.Did a classic preconditioning study provide a clue to the identity of the mitochondrial permeability transition pore?Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial.Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion.Evidence for antioxidants consumption in the coronary blood of patients with an acute myocardial infarction.Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heartRemote ischemic conditioning.Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury.The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.Nerve growth factor protects the ischemic heart via attenuation of the endoplasmic reticulum stress induced apoptosis by activation of phosphatidylinositol 3-kinase.Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivoHeart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigsIschemic postconditioning protects cardiomyocytes against ischemia/reperfusion injury by inducing MIP2
P2860
Q24289195-8CFF7AEE-2BED-42EB-B5D9-4B84809F69BEQ26778211-AEF26C94-D355-492B-AF76-DAB1BC5E4751Q26825240-110E9FDE-92B9-4BD0-AAAD-192F7A42B710Q26825733-DEBAC7ED-79C4-4F9D-86FB-686D526549D1Q26828968-15192E2D-2EAC-4B45-A2B2-2BF68B4FFF54Q26830560-3BC0462E-FF00-4835-9050-D7B8EE902088Q26853129-79B770BC-542B-457C-BD99-D977EB26B643Q26866366-DF723220-F0E9-4D0C-BF9C-22025772F71DQ27000466-D1BBC57D-E033-402B-95C3-E8F9D1656A3BQ27021021-CDB01FC2-D85C-4709-8A49-729C98767FCEQ28248925-DDFC1B50-291E-4027-9C33-EDA0DC1D515EQ28539671-06C302BD-062B-43FA-85E6-606A4479195AQ28546468-20D077D0-DA57-43EA-B7DF-540ADA935B2DQ28580796-D4CE306F-ADBF-4770-811C-6A4AAE875E2CQ30462352-D5209CF1-444D-4AE9-A46F-E2E5949EAC77Q30844779-6AE1689C-11D4-43A4-B3B4-1C519E41282EQ33614135-19438401-D2B6-41F1-B6A3-939C109401E5Q33740085-67FF0C69-11FA-42FD-B843-CD7FC27AE463Q33788999-4F5E9B52-6F6E-49CD-A260-0ABA2E406EACQ33812924-CEA40381-105F-4C3D-81B3-BA68B79B2728Q33852943-DE1CD53C-1830-4058-AE15-037F7945FEECQ33937622-EEE543E8-5A96-41F5-97D4-64C0804A0BB3Q34004756-DB5493B2-EBA5-4E16-A0D7-73CA8C78ED42Q34206337-78EB45F2-5AD0-4581-932F-340E75768319Q34215980-457100CA-8EFB-4EDA-A31F-C6E46B2F7518Q34238262-94D02F1A-1782-4459-BF09-4C19D6E20F1CQ34247485-A04742BF-8526-40F4-8522-98DFAFAD5B67Q34268690-7E7E4ABB-A1B1-4C50-9FEC-47E09F81AFBDQ34297010-2BD1D8F0-7476-41C3-B2DE-9BBC8A80EDEBQ34300508-809A5BD0-DFE9-43D9-A8D3-6370C3DCA690Q34338140-7867FC4D-880C-4A84-82E8-06D6C77C6539Q34388245-E292B14B-444C-4090-86B3-3121947093E3Q34458416-C463431C-5914-4E01-B804-A24E89D38095Q34497101-1ED7C0E0-D8DF-4EB3-B0BD-DAABBEB42937Q34637342-41E3DBBB-148D-4025-BC96-D2019FE183EEQ34784766-C5F558F0-8088-4567-80BD-2C68124CEF45Q34855009-F7E0B022-EF06-41C8-9E3B-422DEC19C0B6Q35031662-7F58EE33-15B6-481E-B880-8BDC9D25F9A2Q35085312-1EB7869F-86B0-4328-B9B2-87680BBBBC79Q35216382-53ADEE77-F9EB-4651-A8FD-2E439B4E2AF6
P2860
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Postconditioning and protectio ...... uropean Society of Cardiology.
@en
Postconditioning and protectio ...... uropean Society of Cardiology.
@nl
type
label
Postconditioning and protectio ...... uropean Society of Cardiology.
@en
Postconditioning and protectio ...... uropean Society of Cardiology.
@nl
prefLabel
Postconditioning and protectio ...... uropean Society of Cardiology.
@en
Postconditioning and protectio ...... uropean Society of Cardiology.
@nl
P2093
P2860
P50
P356
P1476
Postconditioning and protectio ...... uropean Society of Cardiology.
@en
P2093
David Garcia-Dorado
Gerd Heusch
Jakob Vinten-Johansen
Michel Ovize
Péter Ferdinandy
Working Group of Cellular Biology of Heart of European Society of Cardiology
P2860
P304
P356
10.1093/CVR/CVQ129
P577
2010-05-06T00:00:00Z